This trial is testing whether a brain-dedicated PET insert for an MR scanner can be used to study the metabolism and perfusion of Covid-19 negative and positive/once positive subjects.
- Brain Diseases
1 Primary · 0 Secondary · Reporting Duration: Up to 24 months
2 Treatment Groups
Covid-19 Positive/Infected Population
1 of 2
Covid-19 Negative/Uninfected Population
1 of 2
10 Total Participants · 2 Treatment Groups
Primary Treatment: Injected radiotracer with PET Insert · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there any openings for enrolment in this experiment?
"Yes, according to the data presented on clinicaltrials.gov this medical study is still enrolling patients for participation; it was initially posted on July 1st 2022 and amended most recently on October 3rd 2022. Currently, only 10 participants are required from a single site." - Anonymous Online Contributor
What is the total capacity of participants for this trial?
"Affirmative. Clinicaltrials.gov data reveals that this medical trial is open to recruiting, and was originally posted on July 1st 2022 with a most recent update made on October 3rd 2022. The study needs 10 patients from a single centre for participation." - Anonymous Online Contributor